Androgen Receptor in Laryngeal Carcinoma: Could There Be an Androgen-Refractory Tumor?

Table 2

Androgen receptors expression in laryngeal carcinoma. There is correlation with clinicopathological parameters.

Nuclear Androgen Receptor^a
	N	0; 𝑛 (%)	1; 𝑛 (%)	2; 𝑛 (%)	3; 𝑛 (%)	𝑃 value^b
Carcinomas
total	97	46; (47.4)	42; (43.3)	6; (6.2)	3; (3.1)
Grade						0.852
I	25	13; (52)	10; (40)	2; (8)	0; (0)
II	40	19; (47.5)	16; (40)	4; (10)	1; (2.5)
III	32	14; (43.8)	16; (50)	0; (0)	2; (6.2)
TNM Stage						0.890
I	32	13; (40.6)	17; (53.2)	1; (3.1)	1; (3.1)
II	26	14; (53.8)	8; (30.8)	2; (7.7)	2; (7.7)
III	17	9; (53)	7; (41.1)	1; (5.9)	0; (0)
IV	22	10; (45.5)	10; (45.5)	2; (9)	0; (0)

^aAR expression was scored as described in methods. ^bKruskal-Wallis or Mann-Whitney test; 𝑃<0.05 was considered statistically significant.